Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherLiab,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,longTermDebt,inventory,capitalSurplus,otherCurrentAssets,retainedEarnings,goodWill,treasuryStock,shortLongTermDebt,otherStockholderEquity,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,repurchaseOfStock,dividendsPaid,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,currency,exchange,marketCap,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,market,exchangeDataDelayedBy,shortName,regularMarketPreviousClose,bid,ask,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,SYK.DE,-4243000000.0,376748000,310000000,,662000000,,592000000,1505000000,2772000000,808000000,808000000,,,,,,70000000,4294000000,3486000000,1522000000,-146000000,,592000000,592000000,18063000000.0,19878000000.0,13820000000.0,4252000000.0,33698000000.0,13820000000.0,2892000000.0,3865000000.0,2241000000.0,4252000000.0,1751000000.0,2738000000.0,9032000000.0,84000000.0,2714000000.0,12734000000.0,3431000000.0,,,,,,,,,-10000000.0,37000000.0,-202000000.0,-410000000.0,-676000000.0,159000000.0,53000000.0,3000000.0,3000000.0,878000000.0,241000000.0,-9000000.0,73000000.0,-65000000.0,-319000000.0,-153000000.0,-106000000.0,,,4780000000.0,en-US,US,EQUITY,False,Delayed Quote,233.6,1630510537,0.0,235.5,236.2,232.3,193,EUR,GER,88315756544,7200000,False,False,REGULAR,2,0.0,232.3 - 236.2,de_market,0,"STRYKER CORP.  DL-,10",233.6,233.8,235.0,finmb_94614,XETRA,Stryker Corporation,USD,132,93,68.92001,0.4185087,164.68 - 236.2,-2.5999908,-0.011007582,164.68,236.2,1619539500,1635350700,1635797100,2.41,75.57425,0.010316781,3.091,35.838,224.39714,9.202866,0.04101151,213.20746,20.392548,0.0956465,6.518221,15,Europe/Berlin,CEST,,,,236.2,164.68,224.4,213.21,132,93,376.75M,,333.42M,7.31%,75.26%,,,,,,2.13,0.96%,2.41,1.03%,,65.31%,,"Jun 29, 2021",,,"Dec 31, 2020","Jun 30, 2021",12.82%,22.20%,6.92%,15.68%,16.25B,43.18,55.40%,9.16B,4.54B,2.08B,3.09,,2.32B,6.17,12.73B,92.14,2.12,35.84,3.4B,3.24B,Value,49002,Healthcare,43000,3,9,"Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",Kalamazoo,269 385 2600,MI,4,1609372800,1625097600,8,United States,http://www.stryker.com,86400,5,2825 Airview Boulevard,269 385 1062,Medical Devices
t-1,SYK.DE,-4679000000.0,376748000,288000000,,367000000,,302000000,1394000000,2586000000,723000000,723000000,,,,,,65000000,3953000000,3230000000,1367000000,-356000000,,302000000,302000000,5378000000.0,19953000000.0,13502000000.0,524000000.0,33455000000.0,38000000.0,2619000000.0,3161000000.0,2238000000.0,3953000000.0,1519000000.0,3134000000.0,8979000000.0,74000000.0,2616000000.0,13059000000.0,3473000000.0,1806000000.0,94000000.0,12525000000.0,12803000000.0,-867000000.0,15000000.0,-867000000.0,767000000.0,7000000.0,-37000000.0,-96000000.0,-743000000.0,-1053000000.0,-240000000.0,53000000.0,-705000000.0,-8000000.0,452000000.0,276000000.0,7000000.0,-73000000.0,65000000.0,-19000000.0,153000000.0,-83000000.0,-53000000.0,-238000000.0,5026000000.0,en-US,US,EQUITY,False,Delayed Quote,233.6,1630510537,0.0,235.5,236.2,232.3,193,EUR,GER,88315756544,7200000,False,False,REGULAR,2,0.0,232.3 - 236.2,de_market,0,"STRYKER CORP.  DL-,10",233.6,233.8,235.0,finmb_94614,XETRA,Stryker Corporation,USD,132,93,68.92001,0.4185087,164.68 - 236.2,-2.5999908,-0.011007582,164.68,236.2,1619539500,1635350700,1635797100,2.41,75.57425,0.010316781,3.091,35.838,224.39714,9.202866,0.04101151,213.20746,20.392548,0.0956465,6.518221,15,Europe/Berlin,CEST,,,,236.2,164.68,224.4,213.21,132,93,376.75M,,333.42M,7.31%,75.26%,,,,,,2.13,0.96%,2.41,1.03%,,65.31%,,"Jun 29, 2021",,,"Dec 31, 2020","Jun 30, 2021",12.82%,22.20%,6.92%,15.68%,16.25B,43.18,55.40%,9.16B,4.54B,2.08B,3.09,,2.32B,6.17,12.73B,92.14,2.12,35.84,3.4B,3.24B,Value,49002,Healthcare,43000,3,9,"Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",Kalamazoo,269 385 2600,MI,4,1609372800,1625097600,8,United States,http://www.stryker.com,86400,5,2825 Airview Boulevard,269 385 1062,Medical Devices
t-2,SYK.DE,-5248000000.0,376748000,255000000,,671000000,,568000000,1284000000,2773000000,1104000000,1104000000,,-399000000.0,,,,103000000,4262000000,3158000000,1489000000,-433000000,,568000000,568000000,5554000000.0,21246000000.0,13084000000.0,710000000.0,34330000000.0,38000000.0,2650000000.0,3116000000.0,2943000000.0,5041000000.0,1530000000.0,3175000000.0,9707000000.0,81000000.0,2701000000.0,13230000000.0,3494000000.0,1741000000.0,16000000.0,12462000000.0,12778000000.0,-1157000000.0,761000000.0,-1157000000.0,810000000.0,-3000000.0,126000000.0,-4352000000.0,-807000000.0,-1057000000.0,84000000.0,53000000.0,-4140000000.0,32000000.0,1237000000.0,223000000.0,12000000.0,181000000.0,-113000000.0,-3000000.0,189000000.0,-165000000.0,-31000000.0,-216000000.0,4666000000.0,en-US,US,EQUITY,False,Delayed Quote,233.6,1630510537,0.0,235.5,236.2,232.3,193,EUR,GER,88315756544,7200000,False,False,REGULAR,2,0.0,232.3 - 236.2,de_market,0,"STRYKER CORP.  DL-,10",233.6,233.8,235.0,finmb_94614,XETRA,Stryker Corporation,USD,132,93,68.92001,0.4185087,164.68 - 236.2,-2.5999908,-0.011007582,164.68,236.2,1619539500,1635350700,1635797100,2.41,75.57425,0.010316781,3.091,35.838,224.39714,9.202866,0.04101151,213.20746,20.392548,0.0956465,6.518221,15,Europe/Berlin,CEST,,,,236.2,164.68,224.4,213.21,132,93,376.75M,,333.42M,7.31%,75.26%,,,,,,2.13,0.96%,2.41,1.03%,,65.31%,,"Jun 29, 2021",,,"Dec 31, 2020","Jun 30, 2021",12.82%,22.20%,6.92%,15.68%,16.25B,43.18,55.40%,9.16B,4.54B,2.08B,3.09,,2.32B,6.17,12.73B,92.14,2.12,35.84,3.4B,3.24B,Value,49002,Healthcare,43000,3,9,"Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",Kalamazoo,269 385 2600,MI,4,1609372800,1625097600,8,United States,http://www.stryker.com,86400,5,2825 Airview Boulevard,269 385 1062,Medical Devices
t-3,SYK.DE,-59000000.0,376748000,242000000,,780000000,,621000000,1188000000,2461000000,917000000,917000000,,-399000000.0,,,,159000000,3737000000,2820000000,1276000000,-137000000,,621000000,621000000,3917000000.0,19300000000.0,12986000000.0,580000000.0,32286000000.0,38000000.0,2293000000.0,2766000000.0,7083000000.0,4689000000.0,1627000000.0,2930000000.0,13545000000.0,78000000.0,2426000000.0,12008000000.0,3459000000.0,1736000000.0,23000000.0,12129000000.0,9128000000.0,-917000000.0,1119000000.0,-917000000.0,647000000.0,2000000.0,8000000.0,-69000000.0,-5000000.0,-242000000.0,104000000.0,53000000.0,544000000.0,26000000.0,829000000.0,198000000.0,-2000000.0,27000000.0,-204000000.0,-10000000.0,31000000.0,-69000000.0,-11000000.0,-216000000.0,8856000000.0,en-US,US,EQUITY,False,Delayed Quote,233.6,1630510537,0.0,235.5,236.2,232.3,193,EUR,GER,88315756544,7200000,False,False,REGULAR,2,0.0,232.3 - 236.2,de_market,0,"STRYKER CORP.  DL-,10",233.6,233.8,235.0,finmb_94614,XETRA,Stryker Corporation,USD,132,93,68.92001,0.4185087,164.68 - 236.2,-2.5999908,-0.011007582,164.68,236.2,1619539500,1635350700,1635797100,2.41,75.57425,0.010316781,3.091,35.838,224.39714,9.202866,0.04101151,213.20746,20.392548,0.0956465,6.518221,15,Europe/Berlin,CEST,,,,236.2,164.68,224.4,213.21,132,93,376.75M,,333.42M,7.31%,75.26%,,,,,,2.13,0.96%,2.41,1.03%,,65.31%,,"Jun 29, 2021",,,"Dec 31, 2020","Jun 30, 2021",12.82%,22.20%,6.92%,15.68%,16.25B,43.18,55.40%,9.16B,4.54B,2.08B,3.09,,2.32B,6.17,12.73B,92.14,2.12,35.84,3.4B,3.24B,Value,49002,Healthcare,43000,3,9,"Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.",Kalamazoo,269 385 2600,MI,4,1609372800,1625097600,8,United States,http://www.stryker.com,86400,5,2825 Airview Boulevard,269 385 1062,Medical Devices
